Kriti Nutrients Ltd

Kriti Nutrients Ltd

₹ 110 -8.92%
23 May - close price
About

Incorporated in 1992, Kriti Nutrients Ltd is in the business of Soya Seed Extraction and Manufacturing & Selling of cooking oil[1]

Key Points

Business Overview:[1][2]
KNL is a part of Kriti Group. It is a non-GMO soya-based product manufacturing and processing company. It produces branded refined soya bean oil and value-added protein-based products under the brand Kriti an established name in Central India. The company manufactures soya protein and soya lecithin for downstream industrial users and markets, packages, and brands edible refined oil for its retail consumers.

  • Market Cap 553 Cr.
  • Current Price 110
  • High / Low 167 / 85.0
  • Stock P/E 14.9
  • Book Value 42.3
  • Dividend Yield 0.27 %
  • ROCE 25.0 %
  • ROE 19.0 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Edible Oil Industry: Solvent Extraction

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Dec 2024 Mar 2025
172.27 172.92 200.05
159.47 161.86 193.96
Operating Profit 12.80 11.06 6.09
OPM % 7.43% 6.40% 3.04%
1.17 2.49 1.93
Interest 0.46 0.15 0.18
Depreciation 1.26 1.38 1.40
Profit before tax 12.25 12.02 6.44
Tax % 28.57% 31.36% 23.14%
8.75 8.25 4.92
EPS in Rs 1.75 1.65 0.98
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
684 734
622 686
Operating Profit 62 48
OPM % 9% 7%
4 8
Interest 1 1
Depreciation 5 5
Profit before tax 61 50
Tax % 25% 26%
45 37
EPS in Rs 9.04 7.38
Dividend Payout % 0% 4%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 7%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -18%
Stock Price CAGR
10 Years: 34%
5 Years: 44%
3 Years: 21%
1 Year: 3%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Equity Capital 5 5
Reserves 171 207
12 3
20 23
Total Liabilities 209 238
58 58
CWIP 1 0
Investments 12 45
139 135
Total Assets 209 238

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
50 32
-29 -29
-30 -11
Net Cash Flow -10 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Debtor Days 11 4
Inventory Days 30 22
Days Payable 3 3
Cash Conversion Cycle 38 24
Working Capital Days 40 31
ROCE % 25%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
66.37% 66.37% 66.37% 66.37% 66.67% 66.67% 66.69% 66.69% 66.69% 66.69% 66.69% 66.69%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.03% 0.04% 0.03%
33.63% 33.63% 33.63% 33.62% 33.34% 33.33% 33.31% 33.32% 33.30% 33.29% 33.27% 33.28%
No. of Shareholders 21,56320,71420,35819,98519,73619,59219,13919,66420,12122,24622,21022,382

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents